Virtual gastrointestinal well being corporate Vivante Well being introduced it closed a $31 million Collection B investment spherical led by way of new investor Mercato Companions, bringing its general lift to $47 million.
Well being Catalyst, Intermountain Ventures, SemperVirens, 7wireVentures, Human Capital and Disbursed Ventures participated within the spherical.
WHAT IT DOES
Vivante provides a platform dubbed GIThrive that gives customized care plans. Sufferers can monitor their signs and get admission to tutorial content material and self-guided behavioral well being modules. A coordinated workforce of suppliers could also be to be had by means of the platform, together with dietitians, coaches and well being physicians.
The Illinois-based corporate will use the funding to improve its generation and make bigger its body of workers.
“We’re delighted to have the make stronger of industry-leading capital companions as we execute on our imaginative and prescient at Vivante,” Invoice Snyder, Vivante Well being CEO, stated in a remark. “One in 4 American citizens suffers from a digestive dysfunction or undiagnosed digestive signs that impact their high quality of existence in addition to their healthcare prices. We have now confirmed that our scalable generation platform paired with our complete care workforce ends up in higher well being, decrease prices and a a lot better revel in for the contributors we serve.”
MARKET SNAPSHOT
Vivante raised $16 million in Collection A investment remaining yr, $5.8 million in Collection A1 funding in 2020 and $6 million in 2018.
In 2022, Solera Well being, a virtual platform that provides a market for advantages and persistent illness control methods, introduced it used to be including Vivante and fellow virtual gastrointestinal well being corporate Oshi Well being to its market of advantages and persistent care control equipment.
Different firms within the digital gastrointestinal area come with Salvo Well being, which provides a digital medical institution aimed at other people with power intestine issues akin to irritable bowel syndrome, and Daring Well being, a London-based corporate creating virtual therapeutics for gastrointestinal prerequisites.
